# IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study

> **NCT07034664** · — · RECRUITING · sponsor: **The Third Xiangya Hospital of Central South University** · enrollment: 50 (estimated)

## Conditions studied

- Crohn's Disease
- Guselkumab
- Intestinal Ultrasound
- Predictor

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07034664
- **Lead sponsor:** The Third Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-16
- **Primary completion:** 2027-07-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07034664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07034664, "IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07034664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*